Pasireotide

64 interactions 4 explained in plain English
Also sold as: Signifor
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Ketoconazole Topical Histrelin Implant Octreotide Oxaliplatin Injection Granisetron Transdermal Patch Lenvatinib
62 Major 2 Moderate
All (64) Major (62) Moderate (2)

Major

Pasireotide Ivabradine Corlanor Increased risk of QT prolongation Details Pasireotide Ketoconazole Topical Extina® Foam Increased risk of QT prolongation Details Pasireotide Lefamulin Xenleta Increased risk of QT interval prolongation Details Pasireotide Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Pasireotide Levofloxacin Levaquin Increased risk of QT prolongation Details Pasireotide Levofloxacin Injection Levaquin Increased risk of QT prolongation Details Pasireotide Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Pasireotide Mefloquine Lariam® Increased risk of QT prolongation Details Pasireotide Metronidazole Flagyl An increased risk of QT interval prolongation Details Pasireotide Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Pasireotide Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Pasireotide Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Pasireotide Moxifloxacin Avelox Increased risk of QT prolongation Details Pasireotide Moxifloxacin Injection Avelox Increased risk of QT prolongation Details Pasireotide Moxifloxacin Ophthalmic Moxeza® Increased risk of QT prolongation Details Pasireotide Octreotide Bynfezia Increased risk of QT prolongation Details Pasireotide Octreotide Injection Bynfezia Increased risk of QT prolongation Details Pasireotide Ofloxacin Floxin® Increased risk of QT prolongation Details Pasireotide Ofloxacin Ophthalmic Ocuflox Increased risk of QT prolongation Details Pasireotide Ofloxacin Otic Floxin® Otic Increased risk of QT prolongation Details Pasireotide Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details Pasireotide Oxaliplatin Injection Eloxatin® Increased risk of QT-interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.